Feilding-Mellen Cosmo 4
4 · Atai Beckley N.V. · Filed Nov 6, 2025
Insider Transaction Report
Form 4
Feilding-Mellen Cosmo
Director
Transactions
- Award
Common Shares
2025-11-05+7,702,990→ 7,702,990 total - Award
Stock Option
2025-11-05+40,400→ 40,400 totalExercise: $4.48Exp: 2035-11-05→ Common Shares (40,400 underlying) - Award
Stock Option
2025-11-05+103,000→ 103,000 totalExercise: $4.48Exp: 2035-11-05→ Common Shares (103,000 underlying)
Footnotes (3)
- [F1]On November 5, 2025, the Issuer completed its previously announced acquisition of the entire issued share capital of Beckley Psytech Limited ("Beckley Psytech") not already owned by the Issuer (the "Acquisition") from the shareholders of Beckley Psytech, pursuant to that certain Share Purchase Agreement, dated as of June 2, 2025, by and among the parties thereto, as amended (the "Purchase Agreement"). In connection with the Acquisition, the Company acquired all of the issued and outstanding equity interests of Beckley Psytech in exchange for an aggregate of 103,000,066 common shares of the Issuer, issued directly as share consideration or as underlying replacement awards pursuant to the Purchase Agreement.
- [F2]The stock option shall vest in full on the first anniversary of the grant date.
- [F3]The stock option shall vest in 12 substantially equal monthly installments, beginning on December 5, 2025.